Answers are grounded in this paper and cite their sources.
Health-related quality of life (HRQoL) captures patients’ functional status and symptom burden and may provide prognostic information beyond conventional clinical indicators. We systematically evaluated the association between baseline HRQoL and overall survival (OS) in patients with hepatocellular carcinoma (HCC) across HRQoL domains. PubMed, Embase, Web of Science Core Collection, and Scopus were searched through September 26, 2026. Studies of adults with HCC were eligible if they assessed baseline or pretreatment HRQoL using a validated patient-reported instrument and evaluated its association with survival. The primary effect measure was the multivariable-adjusted hazard ratio (HR) for OS. Evidence was organized into six prespecified HRQoL domains, and overlapping reports were mapped to dataset families. Quantitative synthesis required at least three independent datasets with sufficiently comparable estimates. Random-effects meta-analysis used restricted maximum likelihood estimation with Hartung–Knapp inference. Risk of bias was assessed using QUIPS, and certainty of evidence using GRADE for prognostic factor studies. The searches identified 11,029 records, of which 5,863 remained after removal of 5,166 duplicates. Fourteen eligible reports representing 13 independent dataset families were included. Role functioning/functional well-being was the only domain meeting the prespecified criteria for meta-analysis. Three independent datasets provided multivariable-adjusted estimates for OS that could be harmonized per 10-point worsening in EORTC QLQ-C30 role functioning. The pooled HR was 1.080 (standard Hartung–Knapp 95% CI, 1.023–1.140; I² = 0%). The conventional Wald-type REML 95% CI was 1.048–1.113, and the modified Hartung–Knapp 95% CI was 1.012–1.153. The certainty of evidence for this association was rated as low. Evidence for other HRQoL domains was insufficiently comparable for reliable quantitative pooling. Poorer baseline role functioning may be associated with poorer overall survival in patients with HCC, but the certainty of this evidence is low and the pooled estimate is based on only three independent datasets. This prognostic association does not establish incremental predictive value beyond conventional clinical prognostic models or demonstrate that interventions improving HRQoL improve survival. Baseline HRQoL may provide complementary patient-reported information, but its clinical predictive utility requires further validation. PROSPERO CRD420261518209.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: